Evidence map›Paper›PMID 15919953›Full record

ArticleJournal of virology2005

Reversible acid-induced inactivation of the membrane fusion protein of Semliki Forest virus.

Barry-Lee Waarts, Jolanda M Smit, Onwuchekwa J C Aneke, Gerald M McInerney, Peter Liljeström, Robert Bittman, Jan Wilschut

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Barry-Lee WaartsDepartment of Medical Microbiology, Molecular Virology Section, University Medical Center Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Jolanda M Smit
Onwuchekwa J C Aneke
Gerald M McInerney
Peter Liljeström
Robert Bittman
Jan Wilschut
University Medical Center Groningen · NLKarolinska Institutet · SEQueens College, CUNY · US

Funding

STRUCTURAL PROPERTIES OF MEMBRANESR01HL016660 · NHLBI · QUEENS COLLEGE · PI BITTMAN, ROBERT · 1985 to 2003
$1.4M
NHLBI NIH HHS R01 HL016660
6 · The paper itself

Abstract

Previously, it has been shown that the exposure of Semliki Forest virus (SFV) to a mildly acidic environment induces a rapid and complete loss of the ability of the virus to bind and fuse to target membranes added subsequently. In the present study, incubation of SFV at low pH followed by a specific reneutralization step resulted in a partial reversion of this loss of viral fusion capacity, as assessed in a liposomal model system. Also, the ability of the viral E1 fusion protein to undergo liposome-stimulated trimerization was restored. Furthermore, acid-treated and neutralized SFV largely retained infectivity. Exposure of SFV to low pH induced dissociation of the E1/E2 heterodimer, which was not reversed upon neutralization. It is concluded that the SFV E1 fusion protein, after acid-induced dissociation from E2, rapidly adopts an intermediate, nontrimeric conformation in which it is no longer able to interact with target membrane lipids. Neutralization restores the ability of E1 to interact with membranes. This interaction, however, remains strictly dependent on low pH.

Indexed as

AnimalsCell LineCricetinaeDimerizationHydrogen-Ion ConcentrationLiposomesMembrane FusionMembrane GlycoproteinsNeutralization TestsSemliki forest virusViral Envelope ProteinsViral Fusion ProteinsE1 glycoprotein, Semliki forest virusLiposomesMembrane GlycoproteinsViral Envelope ProteinsViral Fusion Proteins

Identifiers

PMID15919953
PMCPMC1143635
OpenAlexW2155923394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.